Crossmark

Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies

Crossref DOI link: https://doi.org/10.1186/s12885-025-13993-5

Published Online: 2025-04-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Hao-Huan

Zhang, Ming-Qing

Zhang, Zi-Chen

Fan, Chen

Li, Shu-Shu

Chen, Wei

Wang, Wei-Dong
Funding

Funding for this research was provided by:

the Soft Science Research Project of the Wuxi (Jiangsu, China) Association for Science and Technology and the Scientific (KX-24-C312)
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Received: 24 July 2024

Accepted: 21 March 2025

First Online: 3 April 2025

Change Date: 9 April 2025

Change Type: Update

Change Details: The equal contributions statement has been updated.

Declarations

:

: The Ethics Committee of Wuxi People’s Hospital, affiliated with Nanjing Medical University, approved this study (No. KY23101) and conducted it in accordance with the tenets of the Declaration of Helsinki. Given the retrospective nature of the study, the Ethics Committee granted an exemption for written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below